Regnum (Regnum) Other Current Liabilities : $-0.00 Mil (As of Mar. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Regnum Other Current Liabilities?

Regnum's other current liabilities for the quarter that ended in Mar. 2023 was $-0.00 Mil.

Regnum's quarterly other current liabilities declined from Sep. 2022 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) and declined from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($-0.00 Mil).

Regnum's annual other current liabilities increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Regnum Other Current Liabilities Historical Data

The historical data trend for Regnum's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regnum Other Current Liabilities Chart

Regnum Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Current Liabilities

Get a 7-Day Free Trial

Regnum Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Regnum Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Regnum Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Regnum's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regnum (Regnum) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

600 Third Avenue, 19th Floor, New York, NY, USA, 10016

Website

https://www.regnumcorp.com

Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.

Regnum (Regnum) Headlines

No Headlines